Introduction

The antibacterial market is the largest infectious disease sector, in terms of both revenue and prescription volume. Although older highly genericised products are still frequently used by physicians, resistance development is driving the uptake of novel higher value products, particularly in the hospital sector. 

Scope

Key data and detailed analysis of the top 29 branded antibacterial products (by 2002 global sales) is provided. 

In depth analysis into key events, strategic options and sales forecasts to 2011 for each of the products profiled. 

Lifecycle and portfolio management strategies are examined with case studies providing useful examples. 

Product positioning techniques are profiled, with suggestions for improvements on past strategies. 

Report Highlights

The antibacterial sector is expected to demonstrate positive, but relatively limited growth to 2011 with a CAGR of 1.8% between 2002 and 2011. Growth will become more reliant on the performance of novel and innovative products, such as Ketek and Zyvox, rather than historical portfolio strength 

Antibacterial market share and sales growth is strongly linked to portfolio content with respect to age of product class. Corporate commitment to the sector appears to be mixed with strategies varying from those of defense, by lifecycle management, and further penetration by boosting product awareness and indications. 

Previously, drug-dosing schedules, IV/oral switching and resultant impacts on treatment cost have determined success in both the hospital and community settings. Datamonitor believes that these sources of product differentiation will remain effective but recognizes new drivers to product development.

Reasons to Purchase

Understand why the number of blockbuster antibacterials will decline by 2011 

Assess a range of lifecycle management strategies to combat the threat of generic incursion in light of the key patent expiries due prior to 2011. 

Quantify future size and scope of antibacterial market and potential for new products. 

Publisher: Datamonitor Infectious Diseases Reports 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_Infectious_Diseases.html#a221